Claims for Patent: 5,665,868

Summary for Patent: 5,665,868

Title:	Chromatographic agent and its use for the separation or proteins, polypeptides of metals
Abstract:	Phosvitin or a modified phosvitin immobilised and coupled to a suitable matrix may be used for the separation and purification of proteins or polypeptides and in the removal of metal ions from biological material. If desired the phosvitin or modified phosvitin may be in the form of a metal chelate complex.
Inventor(s):	Ramadoss; Candadai Seshadri (Bangalore, IN), Lakhey; Hiten Vasant (Bangalore, IN), Krishnaswamy; Patnam Rajagopaliengar (Bangalore, IN)
Assignee:	Vittal Mallya Scientific Research Foundation (Bangalore, IN)
Application Number:	07/759,030
Patent Claims:	1. A process for the purification of a biological material, which comprises the steps of: a. contacting a chromatographic agent comprising a phosvitin-metal chelate complex immobilized and coupled to a matrix effective for chromatography, with a mixture of a biological material comprising a metal-dependent enzyme or a metal-dependent protein, to form a combination complex between said phosvitin-metal chelate complex and said metal-dependent enzyme or said metal-dependent protein, whereby said combination complex is separated from said mixture; and b. eluting said metal-dependent enzyme or said metal-dependent protein to obtain said enzyme or protein in purified form. 2. The process according to claim 1 wherein said metal of the phosvitin-metal chelate complex is selected from the group consisting of Fe.sup.2+, Fe.sup.3+, Zn.sup.++, Cu.sup.++, Mn.sup.2+ and Ca.sup.++. 3. The process according to claim 1 wherein said biological material of said mixture is a metal-dependent enzyme. 4. A process for purification of a protein which comprises the steps of: a. contacting a chromatographic agent comprising a phosvitin immobilized and coupled to a Sepharose chromatographic matrix with a mixture comprising a protein, said protein selected from the group consisting of egg white lysozyme, EcoRI, BamHI, follicle stimulating hormone, adrenocorticotrophic hormone and parathyroid hormone, to form a complex between said phosvitin and said protein, whereby said complex is separated from said mixture; and b. eluting said complex to obtain said protein in purified form. 5. The process according to claim 4 wherein said phosvitin is a 26 kD modified phosvitin that comprises clusters of phosphorylated serine residues. 6. The process according to claim 5 wherein said protein is selected from the group consisting of egg white lysozyme and EcoRI. 7. A process for purification of a biological material which comprises the steps of: a. contacting a chromatographic agent comprising a phosvitin immobilized and coupled to a matrix effective for chromatography, with a mixture of a biological material comprising at least one protein or polypeptide, to form a complex between said phosvitin and said protein or polypeptide, whereby said complex is separated from said mixture; and b. eluting said complex to obtain said protein or polypeptide in purified form; provided that said protein or polypeptide is selected from the group consisting of lysozyme, a growth factor or growth hormone, a DNA modifying enzyme, a DNA binding protein wherein said DNA binding protein is selected from the group consisting of proteins having POU domains, proteins having homeo domains, zinc-finger proteins, leucine zipper proteins and amphipathic helix-loop-helix motif-containing proteins, and a DNA recombinant fusion protein product wherein a protein of interest is fused to a domain of lysozyme comprising charge clusters. 8. A process according to claim 7 wherein the protein or polypeptide does not have phosvitin-specific receptor ligands. 9. A process according to claim 7, wherein said phosvitin is a modified phosvitin. 10. A process according to claim 7, wherein the protein or polypeptide is a lysozyme, a growth hormone, or a DNA modifying enzyme. 11. A process according to claim 7, wherein the protein or polypeptide is selected from the group consisting of lysozyme, ECoRI, Bam HI, FSH, ACTH, or PTH.

Details for Patent 5,665,868

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Nps Pharmaceuticals, Inc.	NATPARA	parathyroid hormone	For Injection	125511	01/23/2015		2014-09-09